Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol versus benzbromarone dose-escalation trial in gout
NL-OMON26727Active, not recruiting
- Sponsor
- drs M.K. Reinders, hospital pharmacist in training Department of Clinical Pharmacy and Pharmacology, Medical Centre Leeuwarden Postbus 888 8901 BR Leeuwarden The Netherlands tel. 0031 58-2866610 E-mail: [email protected]
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in gout and hyperuricemia comparing Allopurinol arm with Benzbromarone arm (2 arms). Primary endpoint: Success on study medication. Started Sep 2006; status: active, not recruiting.
02
Drugs
allopurinolbenzbromarone
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on NL-OMON26727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26727.